4//SEC Filing
Eckhardt Sue Gail 4
Accession 0001209191-22-050551
CIK 0001556263other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:09 PM ET
Size
7.3 KB
Accession
0001209191-22-050551
Insider Transaction Report
Form 4
Eckhardt Sue Gail
Director
Transactions
- Award
Common Stock
2022-09-16+8,000→ 8,000 total - Award
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 totalExercise: $7.35Exp: 2032-09-15→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date. Amounts reported in this Form 4 reflect the 1-for-10 reverse stock split effected by the issuer on September 16, 2022.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001823769
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:09 PM ET
- Size
- 7.3 KB